United States & AstraZeneca
14 shared events · Importance 4 · Last updated Jun 03, 2026
Live sentiment trends, interaction importance charts, and action volume tracking available on the
NewsDesk Dashboard
Domestic
United States: The United States economy faces uncertainty due to new tariffs, with potential for higher inflation, dampened hiring, and increased costs for consumers and businesses.
AstraZeneca: AstraZeneca, among other pharmaceutical companies, had previously announced investments in U.S. production due to the threat of tariffs, but the new, higher tariffs introduce further uncertainty.
Sep 26, 2025 · 7 articles
Accidents
United States: The United States>>> has pledged financial aid and is monitoring the Ebola outbreak, with some of its citizens exposed or infected, but its previous aid cuts and withdrawal from the World Health Organization>>> have been criticized for weakening global health response capacity.
AstraZeneca: AstraZeneca was involved in the development of the COVID-19 vaccine platform that is now being considered for a Bundibugyo ebolavirus vaccine, showcasing its role in vaccine innovation.
May 18, 2026 · 505 articles
Tech
United States: The United States is mentioned in the context of pancreatic cancer mortality projections and orphan drug designations, indicating a relevant market and regulatory environment.
AstraZeneca: AstraZeneca is collaborating on the DURIPANC study, providing its drug Imfinzi, and stands to benefit from the success of the combination therapy.
Jun 01, 2026 · 10 articles
Business
United States: The United States is the region where Roche and Nurix Therapeutics, Inc. will equally split profits and losses from the commercialization of bexobrutideg.
AstraZeneca: AstraZeneca is mentioned as a developer of an approved BTK inhibitor, Calquence, which is a competitor to bexobrutideg.
Jun 07, 2026 · 22 articles
Tech
AstraZeneca: AstraZeneca has partnered with Quell Therapeutics to develop therapies for inflammatory bowel disease, indicating its interest in the field of immune tolerance.
Oct 06, 2025 · 6 articles
Regulatory
AstraZeneca: AstraZeneca, like Pfizer, previously agreed to lower prescription drug costs for United States — Medicaid, contributing to the broader context of the Trump administration's efforts to control drug prices.
Nov 06, 2025 · 6 articles
International
AstraZeneca: AstraZeneca announced a significant investment of $15 billion in China through 2030 to expand its medicines manufacturing and research, demonstrating confidence in the Chinese market.
Jan 30, 2026 · 9 articles
International
AstraZeneca: AstraZeneca's CEO, Pascal Soriot, is part of the business delegation, suggesting potential for increased pharmaceutical and healthcare sector cooperation with China.
Jan 27, 2026 · 34 articles
Regulatory
AstraZeneca: AstraZeneca is mentioned as a collaborator with Innate Pharma, specifically on the monalizumab antibody.
Apr 02, 2026 · 7 articles
Regulatory
AstraZeneca: AstraZeneca is mentioned as a biopharmaceutical company with whom Innate Pharma has established collaborations, including the development of monalizumab.
Apr 13, 2026 · 6 articles
NEWSDESK
Explore this relationship live
Track how United States and AstraZeneca interact across events, view sentiment trends, and discover connected entities.
Open Dashboard